Literature DB >> 21233269

The role of matrix metalloproteinases in cystic fibrosis lung disease.

A Gaggar1, A Hector, P E Bratcher, M A Mall, M Griese, D Hartl.   

Abstract

Significant airway remodelling is a major component of the increased morbidity and mortality observed in cystic fibrosis (CF) patients. These airways feature ongoing leukocytic inflammation and unrelenting bacterial infection. In contrast to acute bacterial pneumonia, CF infection is not cleared efficiently and the ensuing inflammatory response causes tissue damage. This structural damage is mainly a result of free proteolytic activity released by infiltrated neutrophils and macrophages. Major proteases in this disease are serine and matrix metalloproteases (MMPs). While the role of serine proteases, such as elastase, has been characterised in detail, there is emerging evidence that MMPs could play a key role in the pathogenesis of CF lung disease. This review summarises studies linking MMPs with CF lung disease and discusses the potential value of MMPs as future therapeutic targets in CF and other chronic lung diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21233269      PMCID: PMC4036453          DOI: 10.1183/09031936.00173210

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  74 in total

1.  Membrane-bound FRET probe visualizes MMP12 activity in pulmonary inflammation.

Authors:  Amanda Cobos-Correa; Johanna B Trojanek; Stefanie Diemer; Marcus A Mall; Carsten Schultz
Journal:  Nat Chem Biol       Date:  2009-08-02       Impact factor: 15.040

2.  CXCR2 mediates NADPH oxidase-independent neutrophil extracellular trap formation in cystic fibrosis airway inflammation.

Authors:  Veronica Marcos; Zhe Zhou; Ali Onder Yildirim; Alexander Bohla; Andreas Hector; Ljubomir Vitkov; Eva-Maria Wiedenbauer; Wolf Dietrich Krautgartner; Walter Stoiber; Bernd H Belohradsky; Nikolaus Rieber; Michael Kormann; Barbara Koller; Adelbert Roscher; Dirk Roos; Matthias Griese; Oliver Eickelberg; Gerd Döring; Marcus A Mall; Dominik Hartl
Journal:  Nat Med       Date:  2010-09-05       Impact factor: 53.440

3.  Macrophage-specific metalloelastase (MMP-12) truncates and inactivates ELR+ CXC chemokines and generates CCL2, -7, -8, and -13 antagonists: potential role of the macrophage in terminating polymorphonuclear leukocyte influx.

Authors:  Richard A Dean; Jennifer H Cox; Caroline L Bellac; Alain Doucet; Amanda E Starr; Christopher M Overall
Journal:  Blood       Date:  2008-07-25       Impact factor: 22.113

4.  Serum matrix metalloproteinases in adult CF patients: Relation to pulmonary exacerbation.

Authors:  Martin Roderfeld; Timo Rath; Richard Schulz; Werner Seeger; Annette Tschuschner; Jürgen Graf; Elke Roeb
Journal:  J Cyst Fibros       Date:  2009-07-14       Impact factor: 5.482

5.  MMP7 shedding of syndecan-1 facilitates re-epithelialization by affecting alpha(2)beta(1) integrin activation.

Authors:  Peter Chen; Laura E Abacherli; Samuel T Nadler; Ying Wang; Qinglang Li; William C Parks
Journal:  PLoS One       Date:  2009-08-10       Impact factor: 3.240

6.  Association of lower airway inflammation with physiologic findings in young children with cystic fibrosis.

Authors:  Stacey L Peterson-Carmichael; William T Harris; Ruchika Goel; Terry L Noah; Robin Johnson; Margaret W Leigh; Stephanie D Davis
Journal:  Pediatr Pulmonol       Date:  2009-05

7.  Macrophage elastase kills bacteria within murine macrophages.

Authors:  A McGarry Houghton; William O Hartzell; Clinton S Robbins; F Xavier Gomis-Rüth; Steven D Shapiro
Journal:  Nature       Date:  2009-06-17       Impact factor: 49.962

8.  Matrix metalloproteinase-1 cleavage site recognition and binding in full-length human type III collagen.

Authors:  Kim E Williams; David R Olsen
Journal:  Matrix Biol       Date:  2009-04-24       Impact factor: 11.583

9.  Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease.

Authors:  Dominik Hartl; Philipp Latzin; Peter Hordijk; Veronica Marcos; Carsten Rudolph; Markus Woischnik; Susanne Krauss-Etschmann; Barbara Koller; Dietrich Reinhardt; Adelbert A Roscher; Dirk Roos; Matthias Griese
Journal:  Nat Med       Date:  2007-12-02       Impact factor: 53.440

10.  MMP12, lung function, and COPD in high-risk populations.

Authors:  Gary M Hunninghake; Michael H Cho; Yohannes Tesfaigzi; Manuel E Soto-Quiros; Lydiana Avila; Jessica Lasky-Su; Chris Stidley; Erik Melén; Cilla Söderhäll; Jenny Hallberg; Inger Kull; Juha Kere; Magnus Svartengren; Göran Pershagen; Magnus Wickman; Christoph Lange; Dawn L Demeo; Craig P Hersh; Barbara J Klanderman; Benjamin A Raby; David Sparrow; Steven D Shapiro; Edwin K Silverman; Augusto A Litonjua; Scott T Weiss; Juan C Celedón
Journal:  N Engl J Med       Date:  2009-12-16       Impact factor: 176.079

View more
  33 in total

Review 1.  Innate Immunity of the Lung: From Basic Mechanisms to Translational Medicine.

Authors:  Dominik Hartl; Rabindra Tirouvanziam; Julie Laval; Catherine M Greene; David Habiel; Lokesh Sharma; Ali Önder Yildirim; Charles S Dela Cruz; Cory M Hogaboam
Journal:  J Innate Immun       Date:  2018-02-13       Impact factor: 7.349

2.  Neutrophil-targeted, protease-activated pulmonary drug delivery blocks airway and systemic inflammation.

Authors:  Joscelyn C Mejías; Osric A Forrest; Camilla Margaroli; David A Frey Rubio; Liliana Viera; Jindong Li; Xin Xu; Amit Gaggar; Rabindra Tirouvanziam; Krishnendu Roy
Journal:  JCI Insight       Date:  2019-12-05

3.  Benzyloxycarbonyl-proline-prolinal (ZPP): Dual complementary roles for neutrophil inhibition.

Authors:  D W Russell; M Hardison; K R Genschmer; T Szul; P E Bratcher; M Abdul Roda; X Xu; L Viera; J E Blalock; A Gaggar; B D Noerager
Journal:  Biochem Biophys Res Commun       Date:  2019-08-07       Impact factor: 3.575

Review 4.  Matrix metalloproteinases: a review of their structure and role in systemic sclerosis.

Authors:  Wen-jia Peng; Jun-wei Yan; Ya-nan Wan; Bing-xiang Wang; Jin-hui Tao; Guo-jun Yang; Hai-feng Pan; Jing Wang
Journal:  J Clin Immunol       Date:  2012-07-06       Impact factor: 8.317

5.  Airway Surface Liquid Has Innate Antiviral Activity That Is Reduced in Cystic Fibrosis.

Authors:  Abigail R Berkebile; Jennifer A Bartlett; Mahmoud Abou Alaiwa; Steven M Varga; Ultan F Power; Paul B McCray
Journal:  Am J Respir Cell Mol Biol       Date:  2020-01       Impact factor: 6.914

6.  Inhaled alpha1-proteinase inhibitor therapy in patients with cystic fibrosis.

Authors:  Amit Gaggar; Junliang Chen; James F Chmiel; Henry L Dorkin; Patrick A Flume; Rhonda Griffin; David Nichols; Scott H Donaldson
Journal:  J Cyst Fibros       Date:  2015-08-28       Impact factor: 5.482

7.  An interactive network of elastase, secretases, and PAR-2 protein regulates CXCR1 receptor surface expression on neutrophils.

Authors:  Martina Bakele; Amelie S Lotz-Havla; Anja Jakowetz; Melanie Carevic; Veronica Marcos; Ania C Muntau; Soeren W Gersting; Dominik Hartl
Journal:  J Biol Chem       Date:  2014-07-25       Impact factor: 5.157

Review 8.  Targeting Proteases in Cystic Fibrosis Lung Disease. Paradigms, Progress, and Potential.

Authors:  Michael C McKelvey; Sinéad Weldon; Daniel F McAuley; Marcus A Mall; Clifford C Taggart
Journal:  Am J Respir Crit Care Med       Date:  2020-01-15       Impact factor: 21.405

Review 9.  The Airway Microbiome-IL-17 Axis: a Critical Regulator of Chronic Inflammatory Disease.

Authors:  Jenny M Mannion; Rachel M McLoughlin; Stephen J Lalor
Journal:  Clin Rev Allergy Immunol       Date:  2022-03-11       Impact factor: 8.667

10.  Reduced neutrophil elastase inhibitor elafin and elevated transforming growth factor-β1 are linked to inflammatory response in sputum of cystic fibrosis patients with Pseudomonas aeruginosa.

Authors:  Jan C Thomassen; Tobias Trojan; Maxine Walz; Christina Vohlen; Gregor Fink; Ernst Rietschel; Miguel A Alejandre Alcazar; Silke van Koningsbruggen-Rietschel
Journal:  ERJ Open Res       Date:  2021-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.